Progress of multi-genomics in small cell lung cancer / 肿瘤研究与临床

ABSTRACT

Multi-genomic sequencing research has opened the era of targeted precision medicine for non-small cell lung cancer (NSCLC). However, there are few genomic researches on small cell lung cancer (SCLC), and its pathogenesis and driver genes have not been clarified. Difficulties in obtaining tumor tissues, complex tumorigenic factors, rapid disease progression, and unclear mechanism of chemotherapy resistance are the main reasons for the hardly breakthrough in SCLC translational research. Therefore, multi-genomic sequencing research is particularly crucial for the integrated analysis of the genomic characteristics, identification of cancer driver genes and exploration of drug therapeutic targets of SCLC. This article analyzes the results of various published SCLC multi-genomic studies, and makes a preliminary discussion on their clinical relevance.